The combination of GM-CSF with TES caused a nonsignificant reduction in the shift of spleen M-MDSCs toward the PMN-MDSC phenotype (from 15 to 10%) whereas tumor M-MDSCs were still unresponsive (1.3%) (Fig. 2D). The gene discussed is CSF2; the disease is neoplasm.